

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 8.41436394 |
| 2 | complement activation, alternative pathway (GO:0006957) | 8.13945113 |
| 3 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 6.85710852 |
| 4 | exogenous drug catabolic process (GO:0042738) | 6.81655839 |
| 5 | regulation of protein activation cascade (GO:2000257) | 6.70174976 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.50563236 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 6.50563236 |
| 8 | regulation of complement activation (GO:0030449) | 6.45277909 |
| 9 | blood coagulation, intrinsic pathway (GO:0007597) | 6.41870977 |
| 10 | drug catabolic process (GO:0042737) | 6.41057661 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 6.20745659 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.18077218 |
| 13 | lateral sprouting from an epithelium (GO:0060601) | 6.07568911 |
| 14 | mesenchymal-epithelial cell signaling (GO:0060638) | 6.01353685 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 5.98411650 |
| 16 | cell proliferation involved in metanephros development (GO:0072203) | 5.96932732 |
| 17 | cell proliferation involved in kidney development (GO:0072111) | 5.81691835 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 5.77293442 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.77293442 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.77248036 |
| 21 | fibrinolysis (GO:0042730) | 5.62795956 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.61948316 |
| 23 | protein carboxylation (GO:0018214) | 5.59776992 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.59776992 |
| 25 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 5.44598599 |
| 26 | bone trabecula formation (GO:0060346) | 5.43411559 |
| 27 | phenylpropanoid metabolic process (GO:0009698) | 5.16037004 |
| 28 | ethanol oxidation (GO:0006069) | 4.82778672 |
| 29 | negative regulation of norepinephrine secretion (GO:0010700) | 4.75742626 |
| 30 | branching involved in salivary gland morphogenesis (GO:0060445) | 4.73741695 |
| 31 | positive regulation of hemostasis (GO:1900048) | 4.68002551 |
| 32 | positive regulation of blood coagulation (GO:0030194) | 4.68002551 |
| 33 | bile acid biosynthetic process (GO:0006699) | 4.67478760 |
| 34 | protein activation cascade (GO:0072376) | 4.64607279 |
| 35 | glyoxylate metabolic process (GO:0046487) | 4.61695421 |
| 36 | branching involved in prostate gland morphogenesis (GO:0060442) | 4.58579338 |
| 37 | drug metabolic process (GO:0017144) | 4.55397405 |
| 38 | radial glial cell differentiation (GO:0060019) | 4.52953455 |
| 39 | urea metabolic process (GO:0019627) | 4.50533347 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.44049409 |
| 41 | negative regulation of blood coagulation (GO:0030195) | 4.43845758 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.43845758 |
| 43 | negative regulation of osteoblast proliferation (GO:0033689) | 4.36612562 |
| 44 | imidazole-containing compound metabolic process (GO:0052803) | 4.36023427 |
| 45 | cellular response to vitamin D (GO:0071305) | 4.34977208 |
| 46 | craniofacial suture morphogenesis (GO:0097094) | 4.33446082 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 4.29536576 |
| 48 | tonic smooth muscle contraction (GO:0014820) | 4.27737866 |
| 49 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.25248430 |
| 50 | mesenchymal cell proliferation (GO:0010463) | 4.22971262 |
| 51 | protein localization to cell surface (GO:0034394) | 4.22422731 |
| 52 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 4.19625249 |
| 53 | artery smooth muscle contraction (GO:0014824) | 4.17171837 |
| 54 | positive regulation of coagulation (GO:0050820) | 4.16979092 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 4.14504548 |
| 56 | cellular glucuronidation (GO:0052695) | 4.14113381 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.13711164 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.13711164 |
| 59 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 4.13134320 |
| 60 | endothelial cell differentiation (GO:0045446) | 4.10307815 |
| 61 | negative regulation of coagulation (GO:0050819) | 4.09017604 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.08930618 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08930618 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.08930618 |
| 65 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.07504973 |
| 66 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.05741749 |
| 67 | tyrosine metabolic process (GO:0006570) | 4.01513083 |
| 68 | complement activation (GO:0006956) | 4.01125047 |
| 69 | bile acid metabolic process (GO:0008206) | 3.99181443 |
| 70 | regulation of endothelial cell differentiation (GO:0045601) | 3.98775157 |
| 71 | mesodermal cell differentiation (GO:0048333) | 3.97102935 |
| 72 | regulation of plasminogen activation (GO:0010755) | 3.97080448 |
| 73 | oxidative demethylation (GO:0070989) | 3.96773371 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96695667 |
| 75 | negative regulation of wound healing (GO:0061045) | 3.96391125 |
| 76 | S-adenosylmethionine metabolic process (GO:0046500) | 3.93196995 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 3.91134813 |
| 78 | cranial suture morphogenesis (GO:0060363) | 3.90007084 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89558914 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.84351519 |
| 81 | glucuronate metabolic process (GO:0019585) | 3.84351519 |
| 82 | ethanol metabolic process (GO:0006067) | 3.82460863 |
| 83 | renal system development (GO:0072001) | 3.75261793 |
| 84 | opsonization (GO:0008228) | 3.74722465 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.72803582 |
| 86 | urea cycle (GO:0000050) | 3.69722324 |
| 87 | blood vessel maturation (GO:0001955) | 3.65675820 |
| 88 | xenobiotic catabolic process (GO:0042178) | 3.65206200 |
| 89 | negative regulation of sterol transport (GO:0032372) | 3.62712201 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.62712201 |
| 91 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.62540253 |
| 92 | keratinocyte proliferation (GO:0043616) | 3.62321622 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.61950761 |
| 94 | regulation of humoral immune response (GO:0002920) | 3.60657938 |
| 95 | complement activation, classical pathway (GO:0006958) | 3.60440008 |
| 96 | cellular response to cholesterol (GO:0071397) | 3.56380848 |
| 97 | branch elongation of an epithelium (GO:0060602) | 3.50200444 |
| 98 | retinal metabolic process (GO:0042574) | 3.49919930 |
| 99 | regulation of hemostasis (GO:1900046) | 3.47418608 |
| 100 | regulation of blood coagulation (GO:0030193) | 3.47418608 |
| 101 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.46406788 |
| 102 | bile acid and bile salt transport (GO:0015721) | 3.44833951 |
| 103 | cytolysis (GO:0019835) | 3.40013927 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.38449106 |
| 105 | regulation of lipoprotein metabolic process (GO:0050746) | 3.38219006 |
| 106 | lymphangiogenesis (GO:0001946) | 3.36881363 |
| 107 | iron ion import (GO:0097286) | 3.36120504 |
| 108 | smooth muscle tissue development (GO:0048745) | 3.35456229 |
| 109 | regulation of keratinocyte proliferation (GO:0010837) | 3.35305972 |
| 110 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.33785003 |
| 111 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.33785003 |
| 112 | prostate gland epithelium morphogenesis (GO:0060740) | 3.32883072 |
| 113 | negative regulation of JUN kinase activity (GO:0043508) | 3.31137622 |
| 114 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.28842797 |
| 115 | serine family amino acid catabolic process (GO:0009071) | 3.26467765 |
| 116 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.24738037 |
| 117 | somite development (GO:0061053) | 3.24044721 |
| 118 | glomerular filtration (GO:0003094) | 3.23928016 |
| 119 | regulation of osteoblast proliferation (GO:0033688) | 3.23276818 |
| 120 | acute-phase response (GO:0006953) | 3.22869504 |
| 121 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 3.21556460 |
| 122 | positive regulation of cholesterol efflux (GO:0010875) | 3.20885103 |
| 123 | regulation of coagulation (GO:0050818) | 3.19601266 |
| 124 | cell migration involved in heart development (GO:0060973) | 3.18569241 |
| 125 | response to follicle-stimulating hormone (GO:0032354) | 3.16237212 |
| 126 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.16042525 |
| 127 | endocrine process (GO:0050886) | 3.16042525 |
| 128 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.16042525 |
| 129 | positive regulation of sterol transport (GO:0032373) | 3.15063703 |
| 130 | positive regulation of cholesterol transport (GO:0032376) | 3.15063703 |
| 131 | response to BMP (GO:0071772) | 3.14093588 |
| 132 | cellular response to BMP stimulus (GO:0071773) | 3.14093588 |
| 133 | otic vesicle formation (GO:0030916) | 3.13350967 |
| 134 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.11515286 |
| 135 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.11513031 |
| 136 | platelet degranulation (GO:0002576) | 3.10250507 |
| 137 | cellular ketone body metabolic process (GO:0046950) | 3.09982878 |
| 138 | renal filtration (GO:0097205) | 3.08610281 |
| 139 | cellular response to prostaglandin stimulus (GO:0071379) | 3.08058095 |
| 140 | axis elongation (GO:0003401) | 3.07917084 |
| 141 | plasma lipoprotein particle organization (GO:0071827) | 3.07845314 |
| 142 | positive regulation of wound healing (GO:0090303) | 3.07836072 |
| 143 | digestive tract morphogenesis (GO:0048546) | 3.06764789 |
| 144 | dorsal/ventral axis specification (GO:0009950) | 3.05629245 |
| 145 | trabecula formation (GO:0060343) | 3.04375822 |
| 146 | lung lobe morphogenesis (GO:0060463) | 3.03116838 |
| 147 | amino-acid betaine metabolic process (GO:0006577) | 3.02107718 |
| 148 | phospholipid efflux (GO:0033700) | 3.01202521 |
| 149 | cellular response to vitamin (GO:0071295) | 2.99690143 |
| 150 | glycine metabolic process (GO:0006544) | 2.98084780 |
| 151 | arginine catabolic process (GO:0006527) | 2.97583684 |
| 152 | valine metabolic process (GO:0006573) | 2.97170118 |
| 153 | arginine metabolic process (GO:0006525) | 2.95920074 |
| 154 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.95652571 |
| 155 | atrioventricular valve morphogenesis (GO:0003181) | 2.94806800 |
| 156 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.93648203 |
| 157 | positive regulation of fat cell differentiation (GO:0045600) | 2.93295343 |
| 158 | triglyceride catabolic process (GO:0019433) | 2.92046195 |
| 159 | protein heterotrimerization (GO:0070208) | 2.91740232 |
| 160 | mesenchymal cell differentiation (GO:0048762) | 2.91515765 |
| 161 | lymph vessel development (GO:0001945) | 2.91479369 |
| 162 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.91413426 |
| 163 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.91413426 |
| 164 | negative regulation of osteoclast differentiation (GO:0045671) | 2.91341146 |
| 165 | plasma lipoprotein particle clearance (GO:0034381) | 2.91170690 |
| 166 | protein-lipid complex subunit organization (GO:0071825) | 2.90940737 |
| 167 | vascular smooth muscle contraction (GO:0014829) | 2.90612423 |
| 168 | negative regulation of humoral immune response (GO:0002921) | 2.90091747 |
| 169 | glutamate metabolic process (GO:0006536) | 2.86917082 |
| 170 | cellular response to sterol (GO:0036315) | 2.86346089 |
| 171 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.86239487 |
| 172 | positive regulation of cell junction assembly (GO:1901890) | 2.85405402 |
| 173 | positive regulation of focal adhesion assembly (GO:0051894) | 2.85405402 |
| 174 | negative regulation of complement activation (GO:0045916) | 2.84443457 |
| 175 | limb bud formation (GO:0060174) | 2.82920901 |
| 176 | negative regulation of catecholamine secretion (GO:0033604) | 2.82142362 |
| 177 | lung epithelium development (GO:0060428) | 2.82088407 |
| 178 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.82027103 |
| 179 | transcytosis (GO:0045056) | 2.81074397 |
| 180 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.80993846 |
| 181 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.79658967 |
| 182 | hair follicle morphogenesis (GO:0031069) | 2.75708639 |
| 183 | basement membrane organization (GO:0071711) | 2.73050284 |
| 184 | lung alveolus development (GO:0048286) | 2.72221306 |
| 185 | hormone catabolic process (GO:0042447) | 2.71126874 |
| 186 | organ formation (GO:0048645) | 2.70627792 |
| 187 | response to prostaglandin E (GO:0034695) | 2.70468134 |
| 188 | hindlimb morphogenesis (GO:0035137) | 2.70323927 |
| 189 | negative regulation of protein activation cascade (GO:2000258) | 2.69969080 |
| 190 | organ induction (GO:0001759) | 2.68816702 |
| 191 | endothelium development (GO:0003158) | 2.68454125 |
| 192 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.66647780 |
| 193 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.65731587 |
| 194 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.65731587 |
| 195 | negative regulation of platelet activation (GO:0010544) | 2.65302576 |
| 196 | midgut development (GO:0007494) | 2.63345827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.88518948 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.75253170 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.51138251 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20107142 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.04378458 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 2.86988138 |
| 7 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.83177005 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75515911 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56624359 |
| 10 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.50784941 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38243509 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.30420517 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.30420517 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.30420517 |
| 15 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.20476407 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19584205 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.16238810 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15775447 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00785181 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97515473 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97296907 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97089123 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95998869 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.92048421 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87679854 |
| 26 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87606967 |
| 27 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86951516 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84281168 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.83558205 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.80611639 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78486746 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78209501 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.77857305 |
| 34 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76428770 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75263790 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75245758 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71764392 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70918545 |
| 39 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64133083 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.60411457 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59368067 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56654212 |
| 43 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55340115 |
| 44 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54607412 |
| 45 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53717874 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51205592 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51205592 |
| 48 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50096250 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48533900 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48533900 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.48531100 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47323908 |
| 53 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47315392 |
| 54 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.46683616 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46045305 |
| 56 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45685780 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44140593 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43613809 |
| 59 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.43452587 |
| 60 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40239981 |
| 61 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.38201371 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37704967 |
| 63 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36613604 |
| 64 | NFYA_21822215_ChIP-Seq_K562_Human | 1.36386478 |
| 65 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36077986 |
| 66 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35875866 |
| 67 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35486693 |
| 68 | NFYB_21822215_ChIP-Seq_K562_Human | 1.35078332 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34972993 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33136738 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33015209 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32840498 |
| 73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32548878 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30542002 |
| 75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.30180374 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29807700 |
| 77 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29746819 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27055367 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26897044 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26278626 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25596319 |
| 82 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24643419 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24203354 |
| 84 | TBL1_22424771_ChIP-Seq_293T_Human | 1.23603230 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23285895 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22839742 |
| 87 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.22306038 |
| 88 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.21394674 |
| 89 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21339344 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21170598 |
| 91 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.19878576 |
| 92 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.18931198 |
| 93 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18736933 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18319996 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17677821 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16961141 |
| 97 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15725679 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15375659 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14900317 |
| 100 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13353242 |
| 101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13337036 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13268440 |
| 103 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.13012343 |
| 104 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12717397 |
| 105 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.12379013 |
| 106 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.11807509 |
| 107 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.09591294 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09556087 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09485855 |
| 110 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09342148 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08719326 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08244786 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07720211 |
| 114 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07070283 |
| 115 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06760186 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06598140 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06153785 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05932186 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05356086 |
| 120 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05093509 |
| 121 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04548200 |
| 122 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.03806568 |
| 123 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02500646 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02304786 |
| 125 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02301524 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02023141 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01836383 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01593052 |
| 129 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01465431 |
| 130 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01424262 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00973231 |
| 132 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00848343 |
| 133 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00437837 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99639210 |
| 135 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99572081 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99452501 |
| 137 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99433465 |
| 138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99100970 |
| 139 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99095356 |
| 140 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99095356 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98534994 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98222908 |
| 143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98096718 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97828947 |
| 145 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97041577 |
| 146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96749211 |
| 147 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96587777 |
| 148 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96232746 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95762638 |
| 150 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94291737 |
| 151 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93626115 |
| 152 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93314895 |
| 153 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93244026 |
| 154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93045474 |
| 155 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92727761 |
| 156 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90915058 |
| 157 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90778887 |
| 158 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89687046 |
| 159 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89402772 |
| 160 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89142086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 4.76443515 |
| 2 | MP0006054_spinal_hemorrhage | 4.15286711 |
| 3 | MP0010368_abnormal_lymphatic_system | 4.13744614 |
| 4 | MP0003195_calcinosis | 3.71964929 |
| 5 | MP0004147_increased_porphyrin_level | 3.61573067 |
| 6 | * MP0004272_abnormal_basement_membrane | 3.55115226 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.33738594 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 3.32298106 |
| 9 | MP0005248_abnormal_Harderian_gland | 3.28220205 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.25774091 |
| 11 | MP0003724_increased_susceptibility_to | 3.03593037 |
| 12 | MP0002938_white_spotting | 2.98528438 |
| 13 | MP0000566_synostosis | 2.97615116 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.93464021 |
| 15 | * MP0010329_abnormal_lipoprotein_level | 2.77679951 |
| 16 | MP0001879_abnormal_lymphatic_vessel | 2.64151503 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.51008651 |
| 18 | * MP0005187_abnormal_penis_morphology | 2.40105692 |
| 19 | MP0001958_emphysema | 2.38261051 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.27848153 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.27848153 |
| 22 | MP0002295_abnormal_pulmonary_circulatio | 2.26238746 |
| 23 | MP0003011_delayed_dark_adaptation | 2.20134870 |
| 24 | MP0003279_aneurysm | 2.19465790 |
| 25 | MP0003868_abnormal_feces_composition | 2.08904787 |
| 26 | MP0000767_abnormal_smooth_muscle | 2.04808538 |
| 27 | MP0001299_abnormal_eye_distance/ | 2.04160868 |
| 28 | MP0009250_abnormal_appendicular_skeleto | 1.96318434 |
| 29 | MP0004134_abnormal_chest_morphology | 1.95450183 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.93064044 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.85395817 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.84253075 |
| 33 | MP0005508_abnormal_skeleton_morphology | 1.78584758 |
| 34 | MP0005083_abnormal_biliary_tract | 1.77535330 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.72659333 |
| 36 | * MP0005332_abnormal_amino_acid | 1.71380066 |
| 37 | MP0000427_abnormal_hair_cycle | 1.66105947 |
| 38 | MP0002282_abnormal_trachea_morphology | 1.61817389 |
| 39 | MP0000462_abnormal_digestive_system | 1.59678374 |
| 40 | MP0005670_abnormal_white_adipose | 1.59169185 |
| 41 | MP0000579_abnormal_nail_morphology | 1.58697365 |
| 42 | MP0003252_abnormal_bile_duct | 1.57451652 |
| 43 | * MP0000609_abnormal_liver_physiology | 1.54791717 |
| 44 | * MP0002118_abnormal_lipid_homeostasis | 1.54624989 |
| 45 | MP0002098_abnormal_vibrissa_morphology | 1.52433121 |
| 46 | MP0000428_abnormal_craniofacial_morphol | 1.49265097 |
| 47 | MP0003385_abnormal_body_wall | 1.48916010 |
| 48 | MP0002132_abnormal_respiratory_system | 1.48795882 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.47008784 |
| 50 | MP0005275_abnormal_skin_tensile | 1.46999329 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.43850527 |
| 52 | MP0004130_abnormal_muscle_cell | 1.41774974 |
| 53 | * MP0005595_abnormal_vascular_smooth | 1.40855519 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.39956105 |
| 55 | MP0000516_abnormal_urinary_system | 1.36234430 |
| 56 | MP0005367_renal/urinary_system_phenotyp | 1.36234430 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.35870980 |
| 58 | * MP0008775_abnormal_heart_ventricle | 1.35629923 |
| 59 | MP0002009_preneoplasia | 1.35062121 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.33851350 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.30346555 |
| 62 | MP0003941_abnormal_skin_development | 1.30034813 |
| 63 | MP0001243_abnormal_dermal_layer | 1.27805508 |
| 64 | MP0003186_abnormal_redox_activity | 1.26355279 |
| 65 | MP0009697_abnormal_copulation | 1.24549676 |
| 66 | MP0001177_atelectasis | 1.20868250 |
| 67 | MP0002254_reproductive_system_inflammat | 1.20853483 |
| 68 | MP0009278_abnormal_bone_marrow | 1.19974524 |
| 69 | * MP0000598_abnormal_liver_morphology | 1.19928130 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.19380489 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.18387166 |
| 72 | MP0009053_abnormal_anal_canal | 1.18236208 |
| 73 | * MP0000647_abnormal_sebaceous_gland | 1.17786253 |
| 74 | MP0001764_abnormal_homeostasis | 1.17064327 |
| 75 | MP0003091_abnormal_cell_migration | 1.16949379 |
| 76 | MP0002896_abnormal_bone_mineralization | 1.16649785 |
| 77 | MP0003942_abnormal_urinary_system | 1.15827036 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.13962639 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.13350006 |
| 80 | * MP0005164_abnormal_response_to | 1.11253550 |
| 81 | MP0000762_abnormal_tongue_morphology | 1.10373551 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 1.09358690 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08505595 |
| 84 | MP0005360_urolithiasis | 1.08252901 |
| 85 | MP0003136_yellow_coat_color | 1.07919974 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.07723134 |
| 87 | MP0003879_abnormal_hair_cell | 1.07360828 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 1.07287471 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 1.07106721 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 1.07009219 |
| 91 | MP0004215_abnormal_myocardial_fiber | 1.06045618 |
| 92 | MP0005171_absent_coat_pigmentation | 1.05237178 |
| 93 | MP0001346_abnormal_lacrimal_gland | 1.05027662 |
| 94 | MP0005408_hypopigmentation | 1.03975527 |
| 95 | MP0001542_abnormal_bone_strength | 1.03184944 |
| 96 | MP0000751_myopathy | 1.02353353 |
| 97 | MP0001293_anophthalmia | 1.02228252 |
| 98 | MP0001915_intracranial_hemorrhage | 1.00781815 |
| 99 | MP0002133_abnormal_respiratory_system | 1.00475826 |
| 100 | MP0005388_respiratory_system_phenotype | 1.00475826 |
| 101 | * MP0002971_abnormal_brown_adipose | 0.99601794 |
| 102 | MP0003935_abnormal_craniofacial_develop | 0.98972725 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.98913385 |
| 104 | MP0002115_abnormal_skeleton_extremities | 0.98189471 |
| 105 | MP0003718_maternal_effect | 0.97732746 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.97418471 |
| 107 | MP0001851_eye_inflammation | 0.97110461 |
| 108 | MP0005647_abnormal_sex_gland | 0.96732622 |
| 109 | MP0005409_darkened_coat_color | 0.96168330 |
| 110 | * MP0000249_abnormal_blood_vessel | 0.95940685 |
| 111 | MP0005395_other_phenotype | 0.95887183 |
| 112 | MP0002168_other_aberrant_phenotype | 0.95823787 |
| 113 | MP0004036_abnormal_muscle_relaxation | 0.95787497 |
| 114 | MP0000383_abnormal_hair_follicle | 0.95406243 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.94347677 |
| 116 | * MP0009763_increased_sensitivity_to | 0.93340189 |
| 117 | * MP0002128_abnormal_blood_circulation | 0.92979577 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.92555994 |
| 119 | MP0000163_abnormal_cartilage_morphology | 0.92388049 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.91926298 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 0.91863404 |
| 122 | MP0003828_pulmonary_edema | 0.91611893 |
| 123 | MP0006138_congestive_heart_failure | 0.90559828 |
| 124 | MP0009764_decreased_sensitivity_to | 0.90365883 |
| 125 | * MP0001661_extended_life_span | 0.88770418 |
| 126 | MP0002932_abnormal_joint_morphology | 0.88546228 |
| 127 | MP0002109_abnormal_limb_morphology | 0.87931252 |
| 128 | * MP0001614_abnormal_blood_vessel | 0.87376442 |
| 129 | * MP0002925_abnormal_cardiovascular_devel | 0.86851258 |
| 130 | MP0005390_skeleton_phenotype | 0.86734345 |
| 131 | MP0005023_abnormal_wound_healing | 0.86261161 |
| 132 | MP0008004_abnormal_stomach_pH | 0.83341610 |
| 133 | MP0002139_abnormal_hepatobiliary_system | 0.83278652 |
| 134 | MP0001175_abnormal_lung_morphology | 0.83076181 |
| 135 | MP0003690_abnormal_glial_cell | 0.82854169 |
| 136 | MP0002116_abnormal_craniofacial_bone | 0.82512587 |
| 137 | MP0004885_abnormal_endolymph | 0.81228242 |
| 138 | * MP0004883_abnormal_blood_vessel | 0.79973237 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.79943349 |
| 140 | * MP0009643_abnormal_urine_homeostasis | 0.79310777 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.78674552 |
| 142 | * MP0000230_abnormal_systemic_arterial | 0.77523484 |
| 143 | * MP0005535_abnormal_body_temperature | 0.77359775 |
| 144 | MP0005365_abnormal_bile_salt | 0.76714006 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.76385171 |
| 146 | MP0002060_abnormal_skin_morphology | 0.74807671 |
| 147 | MP0009840_abnormal_foam_cell | 0.74680105 |
| 148 | MP0005319_abnormal_enzyme/_coenzyme | 0.74635304 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.73907740 |
| 150 | * MP0009642_abnormal_blood_homeostasis | 0.73574810 |
| 151 | MP0003938_abnormal_ear_development | 0.73265595 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.72952558 |
| 153 | * MP0000343_altered_response_to | 0.72925916 |
| 154 | * MP0005376_homeostasis/metabolism_phenot | 0.69685274 |
| 155 | * MP0005385_cardiovascular_system_phenoty | 0.66360023 |
| 156 | * MP0001544_abnormal_cardiovascular_syste | 0.66360023 |
| 157 | MP0004808_abnormal_hematopoietic_stem | 0.64674525 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.63842117 |
| 159 | MP0005410_abnormal_fertilization | 0.62528683 |
| 160 | MP0002090_abnormal_vision | 0.60288844 |
| 161 | MP0001727_abnormal_embryo_implantation | 0.59955285 |
| 162 | * MP0002078_abnormal_glucose_homeostasis | 0.56975860 |
| 163 | * MP0005334_abnormal_fat_pad | 0.56200436 |
| 164 | MP0004484_altered_response_of | 0.55476736 |
| 165 | MP0005375_adipose_tissue_phenotype | 0.55214854 |
| 166 | MP0009115_abnormal_fat_cell | 0.54194795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 8.17394318 |
| 2 | Abnormality of the parietal bone (HP:0002696) | 7.02277969 |
| 3 | Abnormality of complement system (HP:0005339) | 6.44481034 |
| 4 | Midline defect of the nose (HP:0004122) | 5.89836233 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.75541141 |
| 6 | Short 4th metacarpal (HP:0010044) | 5.72718894 |
| 7 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 5.72718894 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.60630226 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.57711696 |
| 10 | Menorrhagia (HP:0000132) | 5.49688557 |
| 11 | Poikilocytosis (HP:0004447) | 5.49628748 |
| 12 | Increased mean platelet volume (HP:0011877) | 5.48371917 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.47433658 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 5.18989377 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 5.11756360 |
| 16 | Prolonged bleeding time (HP:0003010) | 5.09467149 |
| 17 | Toxemia of pregnancy (HP:0100603) | 5.01575208 |
| 18 | Abnormal platelet volume (HP:0011876) | 4.90942097 |
| 19 | Joint hemorrhage (HP:0005261) | 4.90642649 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 4.56697451 |
| 21 | Broad metatarsal (HP:0001783) | 4.54356923 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.49147163 |
| 23 | Gingival bleeding (HP:0000225) | 4.41320465 |
| 24 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 4.22298891 |
| 25 | Xanthomatosis (HP:0000991) | 4.21831900 |
| 26 | Nasolacrimal duct obstruction (HP:0000579) | 4.13512237 |
| 27 | Acanthocytosis (HP:0001927) | 4.11308635 |
| 28 | Abnormality of the 4th metacarpal (HP:0010012) | 4.08731265 |
| 29 | Spontaneous abortion (HP:0005268) | 4.05985320 |
| 30 | Epistaxis (HP:0000421) | 4.05704456 |
| 31 | Trigonocephaly (HP:0000243) | 3.98362276 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.97563164 |
| 33 | Abnormality of the nasal septum (HP:0000419) | 3.96621470 |
| 34 | Purpura (HP:0000979) | 3.93247324 |
| 35 | Glomerulonephritis (HP:0000099) | 3.77409928 |
| 36 | Shallow orbits (HP:0000586) | 3.75386838 |
| 37 | Broad face (HP:0000283) | 3.74365101 |
| 38 | Osteomalacia (HP:0002749) | 3.72362907 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 3.71712152 |
| 40 | Abnormal platelet function (HP:0011869) | 3.69609485 |
| 41 | Impaired platelet aggregation (HP:0003540) | 3.69609485 |
| 42 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.68904695 |
| 43 | Aplasia cutis congenita (HP:0001057) | 3.59487696 |
| 44 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.57000755 |
| 45 | Aplasia of the phalanges of the hand (HP:0009802) | 3.57000755 |
| 46 | Aplasia involving bones of the extremities (HP:0009825) | 3.57000755 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49251166 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.44770496 |
| 49 | Reticulocytosis (HP:0001923) | 3.44484563 |
| 50 | Neoplasm of the heart (HP:0100544) | 3.39294153 |
| 51 | Hyperbilirubinemia (HP:0002904) | 3.26190718 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 3.24590229 |
| 53 | Cholecystitis (HP:0001082) | 3.24590229 |
| 54 | Spontaneous hematomas (HP:0007420) | 3.19347460 |
| 55 | Depressed nasal tip (HP:0000437) | 3.14200007 |
| 56 | Cholelithiasis (HP:0001081) | 3.12768122 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.08935185 |
| 58 | Petechiae (HP:0000967) | 3.08443177 |
| 59 | Abnormality of the lacrimal duct (HP:0011481) | 3.04541605 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 3.02293376 |
| 61 | Abnormality of the nasolacrimal system (HP:0000614) | 2.97877068 |
| 62 | Short phalanx of the thumb (HP:0009660) | 2.95186974 |
| 63 | Arthropathy (HP:0003040) | 2.89289381 |
| 64 | Short hallux (HP:0010109) | 2.89196483 |
| 65 | Vitreoretinal degeneration (HP:0000655) | 2.88852141 |
| 66 | Anteriorly placed anus (HP:0001545) | 2.88577131 |
| 67 | Recurrent corneal erosions (HP:0000495) | 2.86815448 |
| 68 | White forelock (HP:0002211) | 2.86269882 |
| 69 | Aortic aneurysm (HP:0004942) | 2.82904072 |
| 70 | Nephritis (HP:0000123) | 2.80985177 |
| 71 | Down-sloping shoulders (HP:0200021) | 2.79039069 |
| 72 | Humeroradial synostosis (HP:0003041) | 2.78721092 |
| 73 | Synostosis involving the elbow (HP:0003938) | 2.78721092 |
| 74 | Abnormality of incisor morphology (HP:0011063) | 2.77883939 |
| 75 | Bone cyst (HP:0012062) | 2.77809256 |
| 76 | Hypolipoproteinemia (HP:0010981) | 2.77423056 |
| 77 | Mitral stenosis (HP:0001718) | 2.73425284 |
| 78 | Alacrima (HP:0000522) | 2.72680818 |
| 79 | Partial duplication of thumb phalanx (HP:0009944) | 2.71716731 |
| 80 | Deep venous thrombosis (HP:0002625) | 2.70963387 |
| 81 | Broad hallux (HP:0010055) | 2.70068807 |
| 82 | Partial duplication of the phalanx of hand (HP:0009999) | 2.69463515 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.68415432 |
| 84 | Premature skin wrinkling (HP:0100678) | 2.65990059 |
| 85 | Coronal craniosynostosis (HP:0004440) | 2.64705670 |
| 86 | Myocardial infarction (HP:0001658) | 2.59237605 |
| 87 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.58196953 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.57273386 |
| 89 | Aortic dissection (HP:0002647) | 2.56688761 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.54493544 |
| 91 | Abnormality of methionine metabolism (HP:0010901) | 2.54368238 |
| 92 | Broad toe (HP:0001837) | 2.49300639 |
| 93 | Premature rupture of membranes (HP:0001788) | 2.47059652 |
| 94 | Infantile muscular hypotonia (HP:0008947) | 2.45426247 |
| 95 | Hypercholesterolemia (HP:0003124) | 2.44459205 |
| 96 | Large earlobe (HP:0009748) | 2.44228048 |
| 97 | Abnormality of the incisor (HP:0000676) | 2.43784785 |
| 98 | Fat malabsorption (HP:0002630) | 2.42323853 |
| 99 | Thrombophlebitis (HP:0004418) | 2.39952480 |
| 100 | Protrusio acetabuli (HP:0003179) | 2.39478537 |
| 101 | Hyperammonemia (HP:0001987) | 2.35875541 |
| 102 | Supernumerary ribs (HP:0005815) | 2.35176322 |
| 103 | Milia (HP:0001056) | 2.32982194 |
| 104 | Conical tooth (HP:0000698) | 2.31033051 |
| 105 | Exostoses (HP:0100777) | 2.30323327 |
| 106 | Preaxial foot polydactyly (HP:0001841) | 2.29215334 |
| 107 | Deformed sella turcica (HP:0002681) | 2.28867272 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.28608945 |
| 109 | Hypoplastic ischia (HP:0003175) | 2.28169619 |
| 110 | Conjunctival telangiectasia (HP:0000524) | 2.26125693 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.23719891 |
| 112 | Bilateral microphthalmos (HP:0007633) | 2.23165354 |
| 113 | Abnormality of the sella turcica (HP:0002679) | 2.22032450 |
| 114 | Rickets (HP:0002748) | 2.20121020 |
| 115 | Epidermoid cyst (HP:0200040) | 2.19890288 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19032830 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.16727205 |
| 118 | Bell-shaped thorax (HP:0001591) | 2.16634534 |
| 119 | Abnormality of the ischium (HP:0003174) | 2.14697793 |
| 120 | Sparse lateral eyebrow (HP:0005338) | 2.14285076 |
| 121 | Rectal fistula (HP:0100590) | 2.14143011 |
| 122 | Rectovaginal fistula (HP:0000143) | 2.14143011 |
| 123 | Paralysis (HP:0003470) | 2.14123252 |
| 124 | Cardiovascular calcification (HP:0011915) | 2.13857319 |
| 125 | Vascular tortuosity (HP:0004948) | 2.13370815 |
| 126 | Peritonitis (HP:0002586) | 2.13140608 |
| 127 | Fair hair (HP:0002286) | 2.13023947 |
| 128 | Turricephaly (HP:0000262) | 2.12548947 |
| 129 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.10630117 |
| 130 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.10256283 |
| 131 | Cerebral hemorrhage (HP:0001342) | 2.08546248 |
| 132 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.08284200 |
| 133 | Abnormal number of incisors (HP:0011064) | 2.08173271 |
| 134 | Flat capital femoral epiphysis (HP:0003370) | 2.06193274 |
| 135 | Arterial tortuosity (HP:0005116) | 2.04951629 |
| 136 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03076171 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 2.02896457 |
| 138 | Vascular calcification (HP:0004934) | 2.02833360 |
| 139 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.01599288 |
| 140 | Pulmonary artery stenosis (HP:0004415) | 2.01163501 |
| 141 | Steatorrhea (HP:0002570) | 2.00756575 |
| 142 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.00728472 |
| 143 | Vaginal fistula (HP:0004320) | 2.00248877 |
| 144 | Decreased lacrimation (HP:0000633) | 2.00102550 |
| 145 | Follicular hyperkeratosis (HP:0007502) | 1.98557664 |
| 146 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97604475 |
| 147 | Esophageal varix (HP:0002040) | 1.97594923 |
| 148 | * Abnormality of the diencephalon (HP:0010662) | 1.96894771 |
| 149 | Abnormal pupillary function (HP:0007686) | 1.96645949 |
| 150 | Microglossia (HP:0000171) | 1.96623435 |
| 151 | Hypochromic microcytic anemia (HP:0004840) | 1.96242084 |
| 152 | Abnormal ossification of hand bones (HP:0005921) | 1.96033588 |
| 153 | Prominent supraorbital ridges (HP:0000336) | 1.94661303 |
| 154 | Hypoalphalipoproteinemia (HP:0003233) | 1.94185051 |
| 155 | Abnormal hand bone ossification (HP:0010660) | 1.94108107 |
| 156 | Bruising susceptibility (HP:0000978) | 1.93219507 |
| 157 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92941020 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.92324447 |
| 159 | Ankle contracture (HP:0006466) | 1.91718701 |
| 160 | Mesomelia (HP:0003027) | 1.91649677 |
| 161 | Cerebral aneurysm (HP:0004944) | 1.91352384 |
| 162 | Decreased skull ossification (HP:0004331) | 1.91340440 |
| 163 | Abnormal delivery (HP:0001787) | 1.89970317 |
| 164 | Bronchomalacia (HP:0002780) | 1.89806840 |
| 165 | Potter facies (HP:0002009) | 1.89378511 |
| 166 | Facial shape deformation (HP:0011334) | 1.89378511 |
| 167 | Concave nail (HP:0001598) | 1.89198309 |
| 168 | Intestinal fistula (HP:0100819) | 1.87935618 |
| 169 | Hypoplasia of the iris (HP:0007676) | 1.86963909 |
| 170 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86633134 |
| 171 | Venous insufficiency (HP:0005293) | 1.86597435 |
| 172 | Microcytic anemia (HP:0001935) | 1.85809804 |
| 173 | Polycythemia (HP:0001901) | 1.83399141 |
| 174 | Abnormality of reticulocytes (HP:0004312) | 1.83149408 |
| 175 | Neoplasm of the oral cavity (HP:0100649) | 1.82410620 |
| 176 | Increased serum ferritin (HP:0003281) | 1.81947151 |
| 177 | Xerostomia (HP:0000217) | 1.80163166 |
| 178 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79278666 |
| 179 | Accelerated skeletal maturation (HP:0005616) | 1.78528475 |
| 180 | Narrow palate (HP:0000189) | 1.77673486 |
| 181 | Wide anterior fontanel (HP:0000260) | 1.77401086 |
| 182 | Joint swelling (HP:0001386) | 1.76494919 |
| 183 | Nausea (HP:0002018) | 1.72845771 |
| 184 | Ileus (HP:0002595) | 1.70942035 |
| 185 | Hyperthyroidism (HP:0000836) | 1.70065765 |
| 186 | Cerebral palsy (HP:0100021) | 1.69083687 |
| 187 | Enlarged kidneys (HP:0000105) | 1.65684682 |
| 188 | Back pain (HP:0003418) | 1.65331546 |
| 189 | Hemorrhage of the eye (HP:0011885) | 1.64302246 |
| 190 | Truncus arteriosus (HP:0001660) | 1.63308584 |
| 191 | Chondrocalcinosis (HP:0000934) | 1.59219107 |
| 192 | Abnormality of Sharpey fibers (HP:0100685) | 1.57780200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.36612609 |
| 2 | FGFR2 | 4.11826925 |
| 3 | LATS1 | 3.54080105 |
| 4 | TGFBR2 | 3.43719850 |
| 5 | PIK3CG | 3.40936747 |
| 6 | MST4 | 3.21942657 |
| 7 | EIF2AK1 | 3.20819183 |
| 8 | PDGFRA | 3.07472244 |
| 9 | AKT3 | 2.80552986 |
| 10 | MYLK | 2.77108259 |
| 11 | DDR2 | 2.58622832 |
| 12 | EPHB2 | 2.48025661 |
| 13 | FER | 2.40532578 |
| 14 | PDK2 | 2.32739727 |
| 15 | BRSK2 | 2.32594242 |
| 16 | NUAK1 | 2.21952115 |
| 17 | TRPM7 | 2.08227430 |
| 18 | KDR | 2.06309047 |
| 19 | EPHB1 | 1.79251923 |
| 20 | KIT | 1.70967022 |
| 21 | PDGFRB | 1.64894024 |
| 22 | RIPK4 | 1.64729000 |
| 23 | MAP3K2 | 1.63663697 |
| 24 | NTRK3 | 1.62738258 |
| 25 | KSR2 | 1.55244647 |
| 26 | BMPR2 | 1.51397802 |
| 27 | PIK3CA | 1.43699672 |
| 28 | TGFBR1 | 1.42979953 |
| 29 | NLK | 1.42169475 |
| 30 | LATS2 | 1.37598942 |
| 31 | EPHA3 | 1.37462518 |
| 32 | RAF1 | 1.37219304 |
| 33 | INSRR | 1.35774310 |
| 34 | PTK2B | 1.35064730 |
| 35 | MAP3K14 | 1.34818390 |
| 36 | MAPK7 | 1.34735228 |
| 37 | SIK1 | 1.30977057 |
| 38 | MAPKAPK3 | 1.29222097 |
| 39 | JAK2 | 1.28416214 |
| 40 | DMPK | 1.26803001 |
| 41 | ERN1 | 1.26294512 |
| 42 | MET | 1.23661331 |
| 43 | NEK6 | 1.16256394 |
| 44 | FGFR1 | 1.16246663 |
| 45 | STK3 | 1.14144089 |
| 46 | TNIK | 1.11835477 |
| 47 | MAP3K4 | 1.10779009 |
| 48 | SCYL2 | 1.08319181 |
| 49 | STK38L | 1.07871632 |
| 50 | CLK1 | 1.07795524 |
| 51 | GRK1 | 1.07289161 |
| 52 | PLK2 | 1.04403391 |
| 53 | PTK6 | 1.04147062 |
| 54 | CSNK1A1L | 1.04088813 |
| 55 | BTK | 1.03774531 |
| 56 | PRKACG | 1.02536975 |
| 57 | BMX | 1.01076146 |
| 58 | IRAK3 | 1.00613681 |
| 59 | MAPK12 | 1.00323949 |
| 60 | TTN | 0.99424899 |
| 61 | RET | 0.99259060 |
| 62 | ILK | 0.97442377 |
| 63 | PINK1 | 0.96174178 |
| 64 | TAOK3 | 0.95884080 |
| 65 | KSR1 | 0.95355033 |
| 66 | ABL2 | 0.92391653 |
| 67 | ERBB3 | 0.89800491 |
| 68 | CCNB1 | 0.88487642 |
| 69 | FLT3 | 0.87794306 |
| 70 | FRK | 0.86366691 |
| 71 | MAP3K6 | 0.83783150 |
| 72 | GSK3A | 0.83374035 |
| 73 | CAMKK2 | 0.81404888 |
| 74 | CSNK1G1 | 0.75092519 |
| 75 | MAP4K2 | 0.73461756 |
| 76 | FGFR4 | 0.73020082 |
| 77 | MAPK15 | 0.71998911 |
| 78 | CHUK | 0.71081851 |
| 79 | PRKD1 | 0.70513845 |
| 80 | EIF2AK3 | 0.69571734 |
| 81 | ZAP70 | 0.69109214 |
| 82 | BMPR1B | 0.69027035 |
| 83 | PRKCE | 0.67931298 |
| 84 | GRK5 | 0.66895976 |
| 85 | PAK2 | 0.66233653 |
| 86 | PRKG1 | 0.64565285 |
| 87 | PAK3 | 0.64329457 |
| 88 | CDC42BPA | 0.64008727 |
| 89 | ROCK1 | 0.63669055 |
| 90 | RIPK1 | 0.63542339 |
| 91 | STK4 | 0.63181300 |
| 92 | EEF2K | 0.62772394 |
| 93 | ERBB4 | 0.62471926 |
| 94 | PRKCQ | 0.62275958 |
| 95 | GRK7 | 0.60146558 |
| 96 | PRKACB | 0.60031504 |
| 97 | MAPKAPK5 | 0.59760648 |
| 98 | CSK | 0.59336456 |
| 99 | ADRBK2 | 0.55984030 |
| 100 | MAP2K1 | 0.55931324 |
| 101 | TEC | 0.55501178 |
| 102 | JAK1 | 0.53750454 |
| 103 | DAPK3 | 0.53125973 |
| 104 | MARK3 | 0.52799082 |
| 105 | IGF1R | 0.52213561 |
| 106 | PTK2 | 0.51921018 |
| 107 | PAK1 | 0.49274413 |
| 108 | ABL1 | 0.49032885 |
| 109 | PLK3 | 0.47758794 |
| 110 | ERBB2 | 0.45754909 |
| 111 | NEK9 | 0.45728952 |
| 112 | PRKCH | 0.44748411 |
| 113 | MAP3K7 | 0.44201464 |
| 114 | RPS6KA5 | 0.44077764 |
| 115 | CSNK1G3 | 0.43977021 |
| 116 | SYK | 0.43759810 |
| 117 | CAMK1D | 0.42842865 |
| 118 | STK39 | 0.42735906 |
| 119 | MAP3K3 | 0.42283262 |
| 120 | MUSK | 0.41846409 |
| 121 | CAMK1 | 0.41833296 |
| 122 | IRAK4 | 0.40896531 |
| 123 | CDK9 | 0.40828046 |
| 124 | ZAK | 0.40565430 |
| 125 | CAMK4 | 0.40507003 |
| 126 | INSR | 0.40181477 |
| 127 | CASK | 0.38953157 |
| 128 | TTK | 0.37873315 |
| 129 | ACVR1B | 0.37700665 |
| 130 | WNK1 | 0.37170092 |
| 131 | MST1R | 0.36933744 |
| 132 | HCK | 0.34605424 |
| 133 | PRKAA2 | 0.34511084 |
| 134 | ADRBK1 | 0.34472185 |
| 135 | MAPK4 | 0.34294041 |
| 136 | MAPK3 | 0.34288454 |
| 137 | DAPK2 | 0.33842338 |
| 138 | PKN1 | 0.33559585 |
| 139 | TBK1 | 0.32913592 |
| 140 | CAMK1G | 0.32873756 |
| 141 | FGFR3 | 0.32519976 |
| 142 | SGK223 | 0.32279837 |
| 143 | SGK494 | 0.32279837 |
| 144 | IKBKE | 0.31995587 |
| 145 | PRKCA | 0.31022559 |
| 146 | EGFR | 0.30400320 |
| 147 | SGK1 | 0.30165448 |
| 148 | IRAK1 | 0.30032453 |
| 149 | STK24 | 0.29939322 |
| 150 | PRKACA | 0.29429652 |
| 151 | PRKAA1 | 0.29034361 |
| 152 | EPHA2 | 0.28791483 |
| 153 | JAK3 | 0.28765851 |
| 154 | EIF2AK2 | 0.28532497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Basal cell carcinoma_Homo sapiens_hsa05217 | 3.24013681 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.13676937 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.99184698 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.83357513 |
| 5 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.67533568 |
| 6 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.58450702 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.03182528 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 2.02136355 |
| 9 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.98266703 |
| 10 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.95508013 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93324979 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76110247 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.73364843 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.73029868 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.67824877 |
| 16 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.64803061 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.64086716 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.62319818 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61214075 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.56272960 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.55284739 |
| 22 | Melanoma_Homo sapiens_hsa05218 | 1.54079608 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49888459 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.45143739 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42323273 |
| 26 | Prostate cancer_Homo sapiens_hsa05215 | 1.41195395 |
| 27 | Pathways in cancer_Homo sapiens_hsa05200 | 1.39799117 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37242986 |
| 29 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.36255590 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.35480035 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33299929 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.30988951 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.28230430 |
| 34 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.25528871 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.22235625 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.21585054 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20227189 |
| 38 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.18125781 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17594057 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15563373 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14894535 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14665846 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14616241 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.14006659 |
| 45 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.13287778 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13129252 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12226448 |
| 48 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.11072793 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10581938 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09955062 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09947779 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09170516 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06844439 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.05938757 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05443256 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04869888 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03633431 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02841921 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01457630 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99287314 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95929939 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.94801632 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.91214513 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88691433 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87350028 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87341034 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.86339720 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85529717 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.84670973 |
| 70 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83950327 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.82233364 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81282255 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78915213 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.78480077 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75398968 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75333597 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.75055304 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74977647 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74959279 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73299883 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70648964 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70582166 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70272271 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68875017 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68136039 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67838631 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67753533 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67417880 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67080160 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66817712 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66766713 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65838384 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65022534 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64206617 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62323355 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61862056 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59056241 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58964523 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58630827 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57835449 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57669851 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53475568 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53055089 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52436007 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51740156 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.51149326 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49691160 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48470868 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48344430 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46004943 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.45998506 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44921167 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44504450 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.44404854 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43704982 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43353605 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43032868 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42714047 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.42626188 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42435041 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42082773 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41233888 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.40368244 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40178769 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39502279 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39337396 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38303625 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37317518 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37140069 |
| 130 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35182750 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29202459 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26391985 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25943474 |
| 134 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21071089 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19409362 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16298374 |
| 137 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.13390318 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.07998644 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07416539 |
| 140 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.03896124 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03729485 |
| 142 | Olfactory transduction_Homo sapiens_hsa04740 | 0.02857425 |
| 143 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02756206 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0086170 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | -0.0015459 |

